Also, our in vitro cell survival and apoptosis assays demonstrated that overexpression of Apaf-1 in melanoma cells enhanced anticancer drug-induced apoptosis, suggesting that Apaf-1 may serve as a therapeutic target in melanoma. Here, APAF1 is linked to melanoma.